Bit Capital Gmb H Syndax Pharmaceuticals Inc Call Options Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
Call Options
2 transactions
Others Institutions Holding SNDX
# of Institutions
232Shares Held
93.8MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$119 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$89.3 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$87.7 Million9.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$73.3 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$63.6 Million0.01% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $849M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...